Accessibility settings

This paper is in the following e-collection/theme issue:

HIV/AIDS/STI Prevention and Care (1086) Prevention and Health Promotion (1482) Pharmacology and Pharmaceutics (127)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50894, first published .
Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study

Authors of this article:

Hongli Chen1, 2 Author Orcid Image ;   Jingjing Hao1 Author Orcid Image ;   Jing Hu1 Author Orcid Image ;   Chang Song1 Author Orcid Image ;   Yesheng Zhou1 Author Orcid Image ;   Miaomiao Li1 Author Orcid Image ;   Jin Chen1 Author Orcid Image ;   Xiu Liu1 Author Orcid Image ;   Dong Wang1 Author Orcid Image ;   Xiaoshan Xu1 Author Orcid Image ;   Peixian Xin1 Author Orcid Image ;   Jiaxin Zhang1 Author Orcid Image ;   Lingjie Liao1 Author Orcid Image ;   Yi Feng1 Author Orcid Image ;   Dan Li1 Author Orcid Image ;   Stephen W Pan3 Author Orcid Image ;   Yiming Shao1 Author Orcid Image ;   Yuhua Ruan1 Author Orcid Image ;   Hui Xing1 Author Orcid Image
Article Authors Cited by (25) Tweetations (2) Metrics

Journals

  1. Zhang J, Sun B, Sheng Z, Ding X, Fan Q, Huang G, Guo Z, Zhong P, Liao L, Xing H, Xia Y, Chai C, Jiang J. Full-Spectrum Surveillance of Pre-Treatment HIV Drug Resistance in Southeastern China. Pharmaceuticals 2024;17(7):900 View
  2. Su Q, Li Y, Huang T, Wei L, He J, Huang Y, Mo G, Qin J, Tao C, Huang X, Ye L, Liang H, Liang B, Huang J. The Prevalence of Pretreatment Drug Resistance and Transmission Networks Among Newly Diagnosed HIV-1-Infected Individuals in Nanning, Guangxi, China. Pathogens 2025;14(4):336 View
  3. Hao J, Liu X, Wang D, Hu H, Li F, Li Y, Hu J, Song C, Ruan Y, Feng Y, Wang Z, Shao Y, Liao L, Xing H. Transmitted HIV-1 Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey. Clinical Infectious Diseases 2025;81(3):531 View
  4. Zhang M, Ma Y, Wang Z, Wang G, Wang Q, Li X, Lin F, Zhang C. Prevalence and transmission of pretreatment drug resistance in people living with HIV-1 in Shanghai China, 2017–2021. Virulence 2024;15(1) View
  5. Lu X, Li Y, Liu M, Wang Y, An N, Sun D, Li Q. Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018–2022. Frontiers in Cellular and Infection Microbiology 2025;15 View
  6. Li X, Li Y, Zhu Z, Tan B, Zhou X, Shi H, Li X, Zhu P, Xu Y. Development and Spatial External Validation of a Predictive Model of Survival Based on Random Survival Forest Analysis for People Living With HIV and AIDS After Highly Active Antiretroviral Therapy in China: Retrospective Cohort Study. Journal of Medical Internet Research 2025;27:e71257 View
  7. He Y, Tang Y, Hua Q, Li X, Ge Y, Liu Y, Tang R, Tian Y, Li W. Exploring Dynamic Changes in HIV-1 Molecular Transmission Networks and Key Influencing Factors: Cross-Sectional Study. JMIR Public Health and Surveillance 2024;10:e56593 View
  8. Okasha H, Afifi A, Ibrahim K, Emad R, Alzahaby A, Abdel-Baki A, Goumaa R, Amer A. Human immunodeficiency virus pretreatment drug resistance to first line antiretroviral therapy: a single center study. The Egyptian Journal of Internal Medicine 2025;37(1) View
  9. Chen Z, Xu J, Jin X, Wang J, Huang J, Zhang H, Chen L, Deng K, Cai W, Li L, Wang F, Wu Z, Shang H, Wu H, Zhang L. Grand Challenges on HIV/AIDS in China – The 5th Symposium, Yunnan 2024. Emerging Microbes & Infections 2025;14(1) View
  10. Zuo Z, Huang W, Liu L, Li M, Chen H, Feng Y, Liao L, Shao Y, Ruan Y, Wu J, Xing H. HIV drug resistance and its associated factors among patients during interruption of antiretroviral therapy in China. Frontiers in Microbiology 2025;16 View
  11. Qin L, Xie Y, Li J, Zhong G, Chen J, Zhu Q, Liang S, Xing H, Liao L, Feng Y, Shao Y, Ruan Y, Lan G, Chen H. Effect of pretreatment HIV drug resistance on mortality, attrition and viral suppression in patients initiating antiretroviral therapy and genetic transmission network: an observational cohort study in Southwest China. Journal of Antimicrobial Chemotherapy 2026;81(3) View
  12. He J, Zhong S, Qin C, Nong A, Lin Z, Liang H, Zhang F, Jiang J, Pan P, Wei W, Liu J, Liu D, Ye L, Liang H, Liang B. The trend, prevalence and potential risk factors of secondary HIV transmission among HIV/AIDS individuals receiving ART in Guangxi, China: a longitudinal cross-sectional study. Emerging Microbes & Infections 2024;13(1) View
  13. Rakotomalala F, Butel C, Rasamoelina T, Serrano L, Vidal N, Randriarimanana S, Maharavo L, Randriamananjara H, Fernandez-Nuñez N, Rabetokotany F, Rakoto D, Delaporte E, Peeters M, Babin F, Samison L, Nerrienet E, Ayouba A. High HIV-1 genetic diversity and low prevalence of transmitted drug resistance among treatment-naive people living with HIV in Madagascar. Infection, Genetics and Evolution 2024;125:105679 View
  14. Mei J, Li J, Chen X, Qiu L, Zhang H, Yu J, Ye L, Zhang D, Cheng D, Chen X. Characteristics and Influencing Factors Among Newly Diagnosed HIV-1 Patients with Non-Marital, Non-Commercial Heterosexual Contact in Lishui, China (2020–2024). Viruses 2025;17(12):1626 View
  15. Li L, Yuan D, Zhao F, Shen Y, Cui C, Moog C, Sun L, Wang B, Liu L, Zhang T, Su B. HIV-1 drug resistance and molecular transmission network analysis of newly diagnosed people living with HIV in Beijing, China: a retrospective study from 2015 to 2023. Virology Journal 2025;22(1) View
  16. Pei R, Zhang Y, Jike C, Yu G, Su L, Wang J, Xiao L, Wang Y, Shen M, Liao J, Zheng Y, Hemelaar J. Prevalence and transmission of HIV-1 drug resistance mutations among patients with treatment failure and newly diagnosed people in Liangshan Prefecture, China, in 2021–2023. Frontiers in Public Health 2025;13 View
  17. Cao D, Xing H, Feng Y, Zhang J, Zhou L, Jiang Z, Chen J, He T. Network Dynamics and Evolutionary Drivers of HIV Drug Resistance in Eastern China, from 2022 to 2024. Viruses 2025;17(11):1516 View
  18. Chen Y, Xu X, Chen H, Zhang X, Zhu Q, Liang S, Xing H, Liao L, Feng Y, Shao Y, Ruan Y, Lan G, Li J. Impact of HIV Pretreatment Drug Resistance on Secondary Transmission Through Treatment Dropout: A Prospective Population-Based Study in Southwestern China. Infection and Drug Resistance 2025;Volume 18:2311 View
  19. Yin Y, Liu Y, Zhu J, Shen P, Chen Y, Jiang Z, Lin H, Ni H, Sun Y. Molecular transmission network analysis of newly diagnosed HIV-1 infections in Ningbo from 2018–2022. Frontiers in Microbiology 2025;16 View
  20. Zhu M, Sun Z, Zhang X, Luo W, Wu S, Ye L, Xu K, Chen J. Epidemiological dynamics and molecular characterization of HIV drug resistance in eastern China from 2020 to 2023. Frontiers in Microbiology 2024;15 View
  21. Xie B, Wang Z, Song Q, Cui M, Deng Y, Zheng F, Krol E, Khouri R, De Clercq E, Mo J, Li G. Geographical and temporal trends of HIV-1 subtypes and drug resistance in China: a nationwide study over two decades (2003–2024). Journal of General Virology 2026;107(2) View
  22. Li J, Mei J, Yu J, Chen X, Zhu J, Ye J, Zhang D, Cheng D, Chen X. Characteristics of molecular epidemiology and transmitted drug resistance among newly diagnosed HIV-1 infections in Lishui, China from 2020 to 2023. Virology Journal 2025;22(1) View
  23. Ouro-Medeli A, Togan R, Serrano L, Butel C, Atoun R, Youa F, Ali-Edje K, Douffan M, Ehlan P, Tegueni K, Amenti R, Konou A, Salou M, Ekouevi D, Peeters M, Dagnra A. Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023: a national study. Frontiers in Public Health 2025;13 View
  24. Li L, Zhou C, Feng L, Zhou J, Zhang Y, Li Y, Wang N, Zhou J, Ren J, Yuan F, Ye L, Yang H, Yang Y, Liang S, Yuan D. Drug Resistance Among Newly Diagnosed People Living with HIV-1 in Sichuan, China: A Large-Scale Population-Based Cross-Sectional Study. Infection and Drug Resistance 2025;Volume 18:6129 View
  25. Li J, Xu Y, Tang Y, Hao J, Song C, Mao W, Li T, Li X, Wang D, Lin L, Yang J, Wu Y, Ruan Y, Feng Y, Wang Y, Xing H, Liao L. Evaluation of a HIV-1 drug resistance genotyping method based on high-throughput sequencing (HTS). BMC Infectious Diseases 2026 View